(26 days)
Not Found
No
The summary describes a mechanical implant for hip replacement and contains no mention of AI, ML, or related concepts.
Yes
The device is a hip implant intended to alleviate pain and disability caused by various forms of arthritis and other conditions, which aligns with the definition of a therapeutic device.
No
The device is an acetabular system intended to resurface the hip socket for total hip replacement, which is a therapeutic surgical procedure, not a diagnostic one.
No
The device description clearly states the device is a modular system for total hip replacement, consisting of a titanium alloy outer shell and a UHMWPE liner, which are physical hardware components.
No, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In vitro diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections. They are used outside of the body (in vitro).
- Device Description and Intended Use: The provided information clearly describes a surgical implant (an acetabular system) used to replace a joint in the hip. This is a device used inside the body (in vivo) during a surgical procedure.
- Lack of IVD Characteristics: The description does not mention any testing of biological samples, analysis of bodily fluids, or diagnostic purposes in the traditional sense of an IVD.
Therefore, based on the provided information, the DePuy Pinnacle Acetabular System is a surgical implant, not an in vitro diagnostic device.
N/A
Intended Use / Indications for Use
The Pinnacle Acetabular System is indicated for total hip replacement in the following conditions:
-
- A severely painful and/or disabled joint from osteoarthritis, traumatic arthritis, rheumatoid arthritis, or congenital hip dysplasia.
-
- Avascular necrosis of the femoral head.
-
- Acute traumatic fracture of the femoral head or neck.
-
- Failed previous hip surgery including joint reconstruction, internal fixation, arthrodesis, hemiarthroplasty, surface replacement arthroplasty, or total hip replacement.
-
- Certain cases of ankylosis.
All Pinnacle porous-coated acetabular shells are indicated for cementless application.
The DePuy Pinnacle Acetabular System is intended to resurface the acetabular socket in cemented or cementless total hip arthroplasty.
Product codes
87 LPH
Device Description
The Pinnacle Acetabular System is part of a modular system for use in total hip replacement. The acetabular component is provided as two separate units, a porous coated hemispherical outer shell manufactured from titanium alloy (Ti-6Al-4V) and a liner manufactured from ultra high molecular weight polyetheylene (UHMWPE), which locks into the outer shell. The liner component articulates with a femoral head of an appropriate diameter.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Hip joint / Acetabular socket
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
The Pinnacle Acetabular System demonstrated adequate performance in design control activities.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 888.3358 Hip joint metal/polymer/metal semi-constrained porous-coated uncemented prosthesis.
(a)
Identification. A hip joint metal/polymer/metal semi-constrained porous-coated uncemented prosthesis is a device intended to be implanted to replace a hip joint. The device limits translation and rotation in one or more planes via the geometry of its articulating surfaces. It has no linkage across the joint. This generic type of device has a femoral component made of a cobalt-chromium-molybdenum (Co-Cr-Mo) alloy or a titanium-aluminum-vanadium (Ti-6Al-4V) alloy and an acetabular component composed of an ultra-high molecular weight polyethylene articulating bearing surface fixed in a metal shell made of Co-Cr-Mo or Ti-6Al-4V. The femoral stem and acetabular shell have a porous coating made of, in the case of Co-Cr-Mo substrates, beads of the same alloy, and in the case of Ti-6Al-4V substrates, fibers of commercially pure titanium or Ti-6Al-4V alloy. The porous coating has a volume porosity between 30 and 70 percent, an average pore size between 100 and 1,000 microns, interconnecting porosity, and a porous coating thickness between 500 and 1,500 microns. The generic type of device has a design to achieve biological fixation to bone without the use of bone cement.(b)
Classification. Class II.
0
DO Boy 088
SUMMARY OF SAFETY AND EFFECTIVENESS ePuy Orthopaedics, Inc.
| NAME OF FIRM: | DePuy Orthopaedics, Inc. P.O. Box 988 700 Orthopaedic Drive Warsaw, IN 46581-0988 | PO Box 988 700 Orthopaedic Drive Warsaw, Indiana 46581-0988 USA Tel: +1 (219) 267 8143 Fax: +1 (219) 267 7196 |
|---|---|---|
| 510(k) CONTACT: | Lynnette Whitaker Manager, Regulatory Affairs | |
| TRADE NAME: | Pinnacle Acetabular System | |
| COMMON NAME: | Acetabular Cup Prosthesis | |
| CLASSIFICATION: | 888.3358 Hip joint metal/polymer semi-constrained cementless prosthesis | |
| DEVICE PRODUCT CODE: | 87 LPH | |
| SUBSTANTIALLY EQUIVALENT DEVICES: | Pinnacle Acetabular System |
DEVICE DESCRIPTION AND INTENDED USE:
The Pinnacle Acetabular System is indicated for total hip replacement in the following conditions:
-
- A severely painful and/or disabled joint from osteoarthritis, traumatic arthritis, rheumatoid arthritis, or congenital hip dysplasia.
-
- Avascular necrosis of the femoral head.
-
- Acute traumatic fracture of the femoral head or neck.
-
- Failed previous hip surgery including joint reconstruction, internal fixation, arthrodesis, hemiarthroplasty, surface replacement arthroplasty, or total hip replacement.
-
- Certain cases of ankylosis.
JUN 1 2 2000
All Pinnacle porous-coated acetabular shells are indicated for cementless application.
The Pinnacle Acetabular System is part of a modular system for use in total hip replacement. The acetabular component is provided as two separate units, a porous coated hemispherical outer shell manufactured from titanium alloy (Ti-6Al-4V) and a liner manufactured from ultra high molecular weight polyetheylene (UHMWPE), which locks into the outer shell. The liner component articulates with a femoral head of an appropriate diameter.
BASIS OF SUBSTANTIAL EQUIVALENCE:
The Pinnacle Acetabular System has the following similarities to the acetabular cup liners that were cleared in K000306: same intended use; same material; same method of manufacture; same design; same sterilization and packaging methods. The Pinnacle Acetabular System demonstrated adequate performance in design control activities.
000000
1
Image /page/1/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular border with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the top half of the circle. Inside the circle is an abstract symbol resembling an eagle or bird with three curved lines representing its wings or feathers, and a human profile in the negative space between the lines.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
JUN 1 2 2000
Ms. Lynnette Whitaker Group Leader, Regulatory Affairs Depuy Orthopedics, Inc. P.O. Box 988 700 Orthopedic Drive Warsaw. Indiana 46581-0988
Re: K001534
Trade Name: Pinnacle Acetabular System Regulatory Class: II Product Code: LPH Dated: May 11, 2000 Received: May 17, 2000
Dear Ms. Whitaker:
We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general control provisions of the Act. The general control provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the current Good Manufacturing Practice requirement, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic (QS) inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.
This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
2
Page 2 - Ms. Lynnette Whitaker
If you desire specific advice for your device on our labeling regulation (21 CFF Part 801 and 11 you desire specific days of the diagnostic devices), please contact the Office of Compliance at additionally 607.10 for questions on the promotion and advertising of your device, (301) 594-4639. Tructionally, 101 quest at (301) 594-4639. Also, please note the regulation prease contact the Office or Compilance an (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Information on your responsibilities and more (800) 638-2041 or at (301) 443-6597, or at its Internet address "http://www.fda.gov/cdrh/dsmamain.html" .
Sincerely yours,
Dune R. Lochner
Image /page/2/Picture/4 description: The image contains a handwritten symbol that resembles a combination of the letters 'G' and 'S'. The symbol is drawn with a continuous line, forming a loop at the top and a curve at the bottom. The symbol is simple and abstract, with no additional details or context provided.
Celia M. Witten, Ph.D., M.D. Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
3
510(k) Number (if known) _ Koo $534
Device Name Pinnacle Acetabular System
Indications for Use:
The DePuy Pinnacle Acetabular System is intended to resurface the acetabular socket in cemented or cementless total hip arthroplasty.
The Pinnacle Acetabular System is indicated for total hip replacement in the following conditions:
-
- A severely painful and/or disabled joint from osteoarthritis, traumatic arthritis, theumatoid arthritis, or congenital hip dysplasia.
-
- Avascular necrosis of the femoral head.
-
- Acute traumatic fracture of the femoral head or neck.
-
- Failed previous hip surgery including joint reconstruction, internal fixation, arthrodesis, hemiarthroplasty, surface replacement arthroplasty, or total hip replacement.
-
- Certain cases of ankylosis.
All Pinnacle porous-coated acetabular shells are indicated for cementless application.
Concurrence of CDRH, Office of Device Evaluation
Donna R. Jochner.
(Division Sign-Off) (Division Sign-On)
Division of General Restorative Devices Division of Section 534
Prescription Use y a (Per 21 CFR 801.109)
OR
Over-The Counter Use _ No
000004